HF
FSTX

HRT Financial’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

HRT Financial’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-109,120
Closed -$558K – 3549
2022
Q3 		$558K Buy
+109,120
New +$685K 0.01% 1364

Other funds holding FSTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's FSTX Position: Q4 2022 in Review

HRT Financial sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2022, closing a stake of 109,120 shares — an estimated $558K sold.

HRT Financial first reported a position in FSTX in Q3 2022 and held it in 1 quarter. The position peaked at $558K in Q3 2022. 59 funds tracked by Wall St. Rank hold FSTX as of Q4 2022.

  • HRT Financial reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 109,120 F-star Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $558K.
  • HRT Financial first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • HRT Financial's F-star Therapeutics, Inc. Common Stock position peaked at $558K in Q3 2022.
  • 59 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.